These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18323545)

  • 61. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells.
    Riethdorf S; Pantel K
    Ann N Y Acad Sci; 2010 Oct; 1210():66-77. PubMed ID: 20973800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma.
    Pachmann K; Camara O; Kroll T; Gajda M; Gellner AK; Wotschadlo J; Runnebaum IB
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1317-27. PubMed ID: 21739182
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
    Schmaltz J
    Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
    [No Abstract]   [Full Text] [Related]  

  • 64. Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy.
    Rovati B; Mariucci S; Delfanti S; Grasso D; Tinelli C; Torre C; De Amici M; Pedrazzoli P
    Cell Oncol (Dordr); 2016 Jun; 39(3):211-28. PubMed ID: 26769126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
    Fehm T; Sagalowsky A; Clifford E; Beitsch P; Saboorian H; Euhus D; Meng S; Morrison L; Tucker T; Lane N; Ghadimi BM; Heselmeyer-Haddad K; Ried T; Rao C; Uhr J
    Clin Cancer Res; 2002 Jul; 8(7):2073-84. PubMed ID: 12114406
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.
    Pizon M; Schott D; Pachmann U; Pachmann K
    Oncotarget; 2016 Jul; 7(30):48143-48154. PubMed ID: 27340862
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.
    Coveler AL; Goodell V; Webster DJ; Salazar LG; Fintak PA; Childs JS; Higgins DM; Disis ML
    Breast Cancer Res Treat; 2009 Jan; 113(1):95-100. PubMed ID: 18236151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model.
    Rostagno P; Moll JL; Bisconte JC; Caldani C
    Anticancer Res; 1997; 17(4A):2481-5. PubMed ID: 9252667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
    Pizon M; Schott DS; Pachmann U; Pachmann K
    Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isolated meningeal relapse following adjuvant chemotherapy for poor prognosis breast cancer.
    Harrison DT; Caggiano V
    Prog Clin Biol Res; 1988; 278():185-96. PubMed ID: 3211935
    [No Abstract]   [Full Text] [Related]  

  • 71. Revised prognostic table to guide practitioners advising patients on adjuvant systematic therapy in early breast cancer.
    Stotter A
    Eur J Surg Oncol; 2007 Dec; 33(10):1211-2. PubMed ID: 17399937
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.
    Hegewisch-Becker S; Braun K; Otte M; Corovic A; Atanackovic D; Nierhaus A; Hossfeld DK; Pantel K
    Clin Cancer Res; 2003 Jun; 9(6):2079-84. PubMed ID: 12796371
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Longtime recirculating tumor cells in breast cancer patients.
    Pachmann K
    Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
    [No Abstract]   [Full Text] [Related]  

  • 74. Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
    Pizon M; Zimon DS; Pachmann U; Pachmann K
    PLoS One; 2013; 8(2):e56836. PubMed ID: 23418605
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High speed detection of circulating tumor cells.
    Hsieh HB; Marrinucci D; Bethel K; Curry DN; Humphrey M; Krivacic RT; Kroener J; Kroener L; Ladanyi A; Lazarus N; Kuhn P; Bruce RH; Nieva J
    Biosens Bioelectron; 2006 Apr; 21(10):1893-9. PubMed ID: 16464570
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Search for tumor cells in the venous blood in relation to postoperative care of cancer patients].
    Peckholz I; Melchert R
    Zentralbl Chir; 1966 Sep; 91(36):1313-7. PubMed ID: 5995396
    [No Abstract]   [Full Text] [Related]  

  • 77. Managing Depression in Patients With Cancer.
    McFarland D; Lahijani S; Holland J
    Oncology (Williston Park); 2016 Jul; 30(7):665-71. PubMed ID: 27422114
    [No Abstract]   [Full Text] [Related]  

  • 78. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center.
    Jacobs BP; Burns B; Marya R; Chapman J; Stone B; Hwang S; Goldman M; Barrows K; Hamolsky D; Sampel K
    Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894
    [No Abstract]   [Full Text] [Related]  

  • 79. Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer.
    Mäurer M; Schott D; Pizon M; Drozdz S; Wendt T; Wittig A; Pachmann K
    Curr Oncol; 2022 Dec; 30(1):261-273. PubMed ID: 36661670
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.
    Pachmann K; Clement JH; Schneider CP; Willen B; Camara O; Pachmann U; Höffken K
    Clin Chem Lab Med; 2005; 43(6):617-27. PubMed ID: 16006258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.